Influence of bioavailability on blood level of mizoribine in kidney transplant recipients.
Ihara
H
H
Departments of Urology, Hyogo College of Medicine, Japan.
Shinkuma
D
D
Kubo
M
M
Miyamoto
I
I
Nojima
M
M
Koike
H
H
Yabumoto
H
H
Ikoma
F
F
D001682:Biological Availability; D002851:Chromatography, High Pressure Liquid; D003404:Creatinine / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D012044:Regression Analysis; D012263:Ribonucleosides / Q000097:blood* / Q000493:pharmacokinetics / Q000627:therapeutic use; D012680:Sensitivity and Specificity
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D003404:Creatinine; D008775:Methylprednisolone